Health
Medical
Cancer Prevention

NeoGenomics

1,823

$21.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (0.23%) Today
$0.00 (0.00%) As of 4:22 PM EDT after-hours

Why Robinhood?

You can buy or sell NeoGenomics and other stocks, options, ETFs, and crypto commission-free!

About NEO

NeoGenomics, Inc. provides cancer diagnostics and pharma services. It operates through a network of cancer focused testing laboratories to provide genetic and molecular testing services. Read More It offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Molecular testing and Pathology consultation. The company operates through two segments: Clinical Services Segment provides various clinical testing services to community-based pathology practices, hospital pathology labs and academic centers with reimbursement from various payers including client direct billing, commercial insurance, Medicare and other government payers, and patients. Pharma Services segment: provides comprehensive testing services in supports pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

CEO
Douglas M. Van Oort
Employees
1,500
Headquarters
Fort Myers, Florida
Founded
1998
Market Cap
2.27B
Price-Earnings Ratio
1.10K
Dividend Yield
0.00
Average Volume
1.23M
High Today
$22.17
Low Today
$21.46
Open Price
$21.76
Volume
2.35M
52 Week High
$26.88
52 Week Low
$11.05

Collections

Health
Medical
Cancer Prevention
Insurance
Pharmaceutical
Finance
US
North America

NEO Earnings

$0.02
$0.04
$0.05
$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.06 per share
Actual
$0.07 per share
Replay Earnings Call
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy NEO

Market Price$21.84
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell NeoGenomics stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up